Toinv

I'm looking for things to keep me positive until these trials are completed. Been reading yours and other posts on stockhouse and agree with Priceless. Something has to give in H1 of 2022. The IP is on the line and RVX is broke. I've studied the corporate update and I am on board until these Covid trials are completed. BP is raking in the $$$s on vaccines and therapies making it difficult for any upstart. This is a tremendous opportunity to get apb on the market thru emergency use authorization. Physicians are all clamoring for tools to fight this with and apb could be the answer for many. The one thing I don't want to see happen is a rush to get trial results and another endpoint failure. Three strikes and you're out and we are 0 and 2. I see Rvx doing the right things - Eversana, a stellar trial advisory group, multiple trial locations, careful screening of patients, efficient trial design, FDA oversight. Patience is a virtue. Let this play out - I am confident it will happen soon - humanity is desperately looking for answers so we can move on. 

Toinv Best wishes to all

Chicagoest